Literature DB >> 31483439

Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab.

Angèle Soria1,2, Aurélie Du-Thanh3, Julien Seneschal4, Marie Jachiet5, Delphine Staumont-Sallé6,7, Sébastien Barbarot8.   

Abstract

Entities:  

Year:  2019        PMID： 31483439      PMCID： PMC6727675          DOI： 10.1001/jamadermatol.2019.2613

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  7 in total

1.  Onychodystrophy associated with dupilumab therapy for atopic dermatitis.

Authors:  Amanda E Zubek; Matthew D Vesely
Journal:  JAAD Case Rep       Date:  2020-11-07

Review 2.  Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review.

Authors:  Paul C Macklis; Brittany Dulmage; Brady Evans; Misha Rosenbach; Johann E Gudjonsson; Benjamin H Kaffenberger
Journal:  Drugs R D       Date:  2020-09

3.  Nomenclature and clinical phenotypes of atopic dermatitis.

Authors:  Giampiero Girolomoni; Marjolein de Bruin-Weller; Valeria Aoki; Kenji Kabashima; Mette Deleuran; Luis Puig; Ashish Bansal; Ana B Rossi
Journal:  Ther Adv Chronic Dis       Date:  2021-03-26       Impact factor: 5.091

Review 4.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

5.  Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study.

Authors:  Andrew Alexis; Marjolein de Bruin-Weller; Stephan Weidinger; Weily Soong; Sebastien Barbarot; Ileana Ionita; Fan Zhang; Hernan Valdez; Claire Clibborn; Natalie Yin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-17

Review 6.  Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.

Authors:  Fumi Miyagawa
Journal:  Biomedicines       Date:  2022-06-23

7.  Dupilumab-associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia-specific IgE: a multicentre, prospective cohort study.

Authors:  Emily Kozera; Thomas Stewart; Kyra Gill; Mae Anne De La Vega; John W Frew
Journal:  Br J Dermatol       Date:  2022-04-19       Impact factor: 11.113
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.